﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>13</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>11</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Screening of Cyclodextrins in the Processing of Buserelin Dry Powders for Inhalation Prepared by Spray Freeze-Drying</ArticleTitle>
    <FirstPage>772</FirstPage>
    <LastPage>783</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.2023.086</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Rostamnezhad</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7674-8419</Identifier>
      </Author>
      <Author>
        <FirstName>Katayoon</FirstName>
        <LastName>Mireskandari</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Rouini</LastName>
      </Author>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Ansari</LastName>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Darabi</LastName>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Vatanara</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-4293-8633</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.2023.086</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>11</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: In this study, we prepared inhalable buserelin microparticles using the spray freeze-drying (SFD) method for pulmonary drug delivery. Raffinose as a cryoprotectant carrier was combined with two levels of five different cyclodextrins (CDs) and then processed by SFD. Methods: Dry powder diameters were evaluated by laser light scattering and morphology was determined by scanning electron microscopy (SEM). Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) analysis were utilized for the determination of crystalline structures. The aerodynamic properties of the spray freeze-dried powders were evaluated by twin stage impinger (TSI) and the stability of prepared samples was assessed under normal and accelerated conditions. Results: The prepared powders were mostly porous spheres and the size of microparticles ranged from 9.08 to 13.53 μm, which are suitable as spray-freeze dried particles. All formulations showed amorphous structure confirmed by DSC and XRD. The aerosolization performance of the formulation containing buserelin, raffinose and 5% beta-cyclodextrin (β-CD), was the highest and its fine particle fraction (FPF) was 69.38%. The more circular and separated structures were observed in higher concentrations of CDs, which were compatible with FPFs. The highest stability was obtained in the formulation containing hydroxypropyl beta-cyclodextrin (HP-β-16. CD) 5%. On the contrary, sulfobutylether beta-cyclodextrin (SBE-β-CD) 5% bearing particles showed the least stability. Conclusion: By adjusting the type and ratio of CDs in the presence of raffinose, the prepared formulations could effectively enhance the aerosolization and stability of buserelin. Therefore, they can be proposed as a suitable career for lung drug delivery.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Spray freeze-drying</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Buserelin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Raffinose</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cyclodextrins</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Microparticles</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Aerodynamic behavior</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>